Phathom Pharmaceuticals Inc. (PHAT)
Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
11. 95
+0.51
+4.458%
$
933.14M Market Cap
- P/E Ratio
- Div Yield
634,203 Volume
-4.59 Eps
$ 11.44
Previous Close 
Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phathom Pharmaceuticals Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Yuen Man Lee Persistent Asset Partners Ltd. | 26,766 | $368,149.88 | $301,652.82 | -$66,497.06 | -18.06% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,588 | $12,882.74 | $17,676.82 | $4,794.08 | 37.21% |
